ClearPoint Neuro (CLPT) Interest Coverage Ratio (2011 - 2026)
ClearPoint Neuro (CLPT) reported Interest Coverage Ratio of 1.57 for Q1 2026, down 127.15% on a YoY basis from 5.8 in Q1 2025, and up 57.34% sequentially from 3.69 in Q4 2025.
ClearPoint Neuro (CLPT) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
ClearPoint Neuro (CLPT) has 15 years of Interest Coverage Ratio data on file, last reported at 1.57 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 127.15% year-over-year to 1.57; the trailing twelve-month figure through Mar 2026 stood at 4.91 (down 101.67% YoY), and the FY2025 full-year result was 2.24, down 49.73% from the prior year.
- Interest Coverage Ratio advanced to 1.57 in Q1 2026, from 3.69 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.25 in Q3 2025 to a low of 148.32 in Q4 2024.
- A 5-year average of 12.76 and a median of 1.2 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 495.66% in 2024 and soared 97.51% in 2025, its largest moves.
- Tracing CLPT's Interest Coverage Ratio over 5 years: stood at 25.98 in 2022, then advanced by 4.17% to 24.9 in 2023, then tumbled by 495.66% to 148.32 in 2024, then soared by 97.51% to 3.69 in 2025, then surged by 57.34% to 1.57 in 2026.
- Business Quant data shows CLPT's Interest Coverage Ratio at 1.57 in Q1 2026, 3.69 in Q4 2025, and 0.25 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | -1.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.57 |
| Dec 31, 2025 | -3.69 |
| Sep 30, 2025 | -0.25 |
| Jun 30, 2025 | -0.64 |
| Mar 31, 2025 | -0.69 |
| Dec 31, 2024 | -148.32 |
| Sep 30, 2024 | -0.63 |
| Jun 30, 2024 | -2.16 |
| Mar 31, 2024 | -1.20 |
| Dec 31, 2023 | -24.90 |
| Sep 30, 2023 | -2.62 |
| Jun 30, 2023 | -1.74 |
| Mar 31, 2023 | -1.07 |
| Dec 31, 2022 | -25.98 |
| Sep 30, 2022 | -0.52 |
| Jun 30, 2022 | -0.40 |
| Mar 31, 2022 | -0.52 |
| Dec 31, 2021 | -39.04 |
| Sep 30, 2021 | -0.25 |
| Jun 30, 2021 | -0.23 |